Evaluation of the safety,reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months |
| |
摘 要: |
|
收稿时间: | 2009-06-28 |
修稿时间: | 2009-07-31 |
本文献已被 ScienceDirect 等数据库收录! |
|